Clinical utility of technetium-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation. 1995

S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
Division of Nuclear Medicine, Department of Radiation Oncology and Nuclear Medicine, Hahnemann University, Philadelphia, PA 19102-1192, USA.

Recently, technetium-99m methoxyisobutylisonitrile (99mTc-MIBI) has been used to image thyroid carcinoma. A prospective study was performed to compare the efficacy of 99mTc-MIBI to thallium-201 (201Tl) scintigraphy in patients with differentiated thyroid carcinoma. The clinical utility of all radionuclide imaging modalities, i.e., 99mTc-MIBI, 201Tl, and iodine-131 Na (131I-Na), as well as serum thyroglobulin estimation, was evaluated. Thirty-four post-thyroidectomy patients (age range: 26-76 years) underwent 45 studies. Histopathologies studied included fourteen papillary, eight papillary-follicular, ten follicular, one Hürthle cell, and one medullary carcinoma of the thyroid. Following optimal stimulation of endogenous thyroid stimulating hormone (i.e, TSH 50 mU/ml), the patients underwent 201Tl and 99mTc-MIBI scintigraphy. Concomitant 131I-Na scintigraphy was performed and serum thyroglobulin levels were measured. Sixteen scan sets were performed prior to 131I-Na ablation therapy. Twenty-nine scan sets were performed following 131I-Na ablation therapy. The presence or absence of thyroid cancer was established by clinical, biochemical, radiologic, and/or biopsy findings. There was no significant difference in sensitivity and specificity of 201Tl scintigraphy versus 99mTc-MIBI scintigraphy in pre- and postablation studies. 131I-Na scintigraphy with determination of thyroglobulin level was sufficient in preablation studies. Among postablation patients, the addition of 99mTc-MIBI or 201Tl offered a higher diagnostic yield. Between the 201Tl and 99mTc-MIBI studies, there was a concordance of 69% in preablation and 97% among postablation patients (P=0.027). It is concluded that 99mTc-MIBI is a suitable alternative to 201Tl scintigraphy in thyroid carcinoma, especially following thyroidectomy and 131I-Na therapy. 131I-Na scintigraphy with serum thyroglobulin is adequate in both pre- and postablation patients. Among the post-131I-Na ablation patients, 99mTc-MIBI or 201Tl is extremely valuable for tumor localization, especially when the 131I-Na whole-body scan is negative. The combination of 99mTc-MIBI or 201Tl scintigraphy with 131I-Na and serum thyroglobulin offers the highest diagnostic yield.

UI MeSH Term Description Entries
D007457 Iodine Radioisotopes Unstable isotopes of iodine that decay or disintegrate emitting radiation. I atoms with atomic weights 117-139, except I 127, are radioactive iodine isotopes. Radioisotopes, Iodine
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D002277 Carcinoma A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for "cancer." Carcinoma, Anaplastic,Carcinoma, Spindle-Cell,Carcinoma, Undifferentiated,Carcinomatosis,Epithelial Neoplasms, Malignant,Epithelioma,Epithelial Tumors, Malignant,Malignant Epithelial Neoplasms,Neoplasms, Malignant Epithelial,Anaplastic Carcinoma,Anaplastic Carcinomas,Carcinoma, Spindle Cell,Carcinomas,Carcinomatoses,Epithelial Neoplasm, Malignant,Epithelial Tumor, Malignant,Epitheliomas,Malignant Epithelial Neoplasm,Malignant Epithelial Tumor,Malignant Epithelial Tumors,Neoplasm, Malignant Epithelial,Spindle-Cell Carcinoma,Spindle-Cell Carcinomas,Tumor, Malignant Epithelial,Undifferentiated Carcinoma,Undifferentiated Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
November 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
September 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
May 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
February 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
March 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
December 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
May 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
January 2007, The Gulf journal of oncology,
S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
July 2006, Annals of nuclear medicine,
S Dadparvar, and A Chevres, and M Tulchinsky, and L Krishna-Badrinath, and A S Khan, and W J Slizofski
June 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!